GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amgen Inc. (AMGN) [hlAlert]

Rating:
Outperform
AMGN
up 143.19 %

Amgen Inc. (AMGN) rated Outperform by Leerink Swann

Posted on: Wednesday,  Aug 20, 2008  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Amgen Inc. (NASDAQ: AMGN) on 08/20/2008, when the stock price was $64.03. Since
then, Amgen Inc. has gained 143.20% as of 08/27/2015's recent price of $155.72.
If you would have followed this Leerink Swann 's recommendation on AMGN, you would have gained 143.19% of your investment in 2563 days.

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/20/2008 8:25 AM Buy
None
64.03
as of 12/24/2008
1 Week up  5.86 %
1 Month up  1.54 %
3 Months down  -6.31 %
1 YTD down  -13.71 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy